Search
for
Sort by
Research 17
- From basal cell carcinoma morphogenesis to the alopecia induced by hedgehog inhibitors: connecting the dots
- Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road
- Unique Tumor Heterogeneity Within a Single Locally Advanced Basal Cell Carcinoma Resulting in Partial Response Despite Continuous Vismodegib Treatment
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Experience with sonidegib in patients with advanced basal cell carcinoma: case reports
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Case Report: PTCH1 splice-site mutation and sonidegib treatment in Gorlin-Goltz syndrome: clinical insights from a family case study
- Medications
- Dermatologic Adverse Events from Cancer Treatments
- Experiences with Smo antagonist vismodegib for the treatment of locally advanced basal cell carcinoma
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- A systematic summary of survival and death signalling during the life of hair follicle stem cells
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors